cystic
fibrosis
cystic
fibrosis
fibrocystic
disease
pancreas
common
inherited
disease
date
still
fatal
outcome
diversity
clinical
manifestations
pathological
findings
added
mysterious
nature
disease
tantalizingly
conflicting
results
biochemical
physical
experimental
studies
many
laboratories
western
world
one
constant
clinical
observations
viscosity
secretion
mucosal
glands
respiratory
alimentary
tracts
ducts
biliary
system
pancreas
approximately
per
cent
patients
cystic
fibrosis
pancreas
earliest
manifestation
meconium
ileus
occurs
neonatal
period
remaining
per
cent
affected
infants
symptoms
generally
become
evident
within
course
first
year
life
lung
symptoms
tend
dominate
clinical
picture
vast
majority
untreated
patients
ultimately
decide
outcome
lower
respiratory
tract
part
involved
nasal
polyps
accumulation
viscous
secretions
paranasal
sinuses
subsequent
bacterial
infection
unusual
pancreatic
deficiency
present
vast
majority
patients
cystic
fibrosis
consists
gross
reduction
complete
absence
exocrine
secretion
although
histological
damage
seen
neonatal
period
infants
suffering
meconium
ileus
general
full
blown
picture
extensive
cirrhosis
portal
hypertension
hepatosplenomegaly
severe
sometimes
fatal
haemorrhages
oesophageal
varices
seen
older
child
adolescent
screening
newborn
enable
institution
protective
measures
lung
complications
arise
attempted
various
techniques
management
includes
diet
pancreatic
enzyme
replacement
treatment
pulmonary
disease
important
aspect
care
patients
cystic
fibrosis
prevention
priority
number
one
management
outlook
child
born
cystic
fibrosis
depends
large
extent
upon
avoidance
delay
adult
life
two
complications
threaten
existence
cor
pulmonale
cirrhosis
liver
